Clindamycin-induced acute kidney injury: large biopsy case series

Honglang Xie1, Huiping Chen, Yangling Hu

  • 1Research Institute of Nephrology, Jinling Hospital, Nanjing University Clinical School of Medicine, Nanjing, PR China.

Abstract

Insights

Clindamycin-induced acute kidney injury (AKI) is uncommon but increasing. This study found AKI often presents with gross hematuria and severe tubular dysfunction, but is largely reversible with treatment.

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Clindamycin-induced acute kidney injury (AKI) is an uncommon but increasingly reported adverse drug reaction.
  • Recent years have seen a rise in documented cases of clindamycin-associated kidney damage.

Purpose of the Study:

  • To investigate the clinical characteristics, renal biopsy findings, and outcomes of patients with clindamycin-induced AKI.
  • To understand the mechanisms and reversibility of kidney injury associated with clindamycin use.

Main Methods:

  • Retrospective analysis of 24 patients diagnosed with clindamycin-induced AKI.
  • Review of patient data including clindamycin dosage, clinical presentation, urine analysis, and renal biopsy results.
  • Assessment of renal function recovery post-treatment and use of clindamycin lymphocyte transformation assay.

Main Results:

  • The majority of patients (23/24) presented with AKI stage 3, often with gross hematuria (15 patients).
  • Renal biopsies confirmed acute interstitial nephritis (AIN) and/or acute tubular necrosis (ATN), linked to tubular toxicity and drug crystals.
  • Severe AKI requiring renal replacement therapy occurred in 87.5% of patients, with significant renal function recovery observed within 2 months post-discharge.

Conclusions:

  • Clindamycin-induced AKI is characterized by severe tubular dysfunction and often gross hematuria.
  • Histopathological findings include AIN and ATN, indicating tubular toxicity as a primary mechanism.
  • Despite severity, clindamycin-induced AKI is largely reversible, highlighting the importance of early diagnosis and management.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...